首页> 外文会议>Conference on ophthalmic measurements and optometry >Monitoring of corneal allograft rejection using laser flare meter
【24h】

Monitoring of corneal allograft rejection using laser flare meter

机译:使用激光闪光表监测角膜异种移植物排斥反应

获取原文
获取外文期刊封面目录资料

摘要

The purpose of this study was to quantify noninvasively, with the use of laser-flare meter the alterations of the blood-aqueous barrier following penetrating keratoplasty. This could diagnose objectively disruption of this barrier in eyes with early allograft rejection, possible even before manifestation of the clinical signs and would help to monitor the efficacy of the treatment. We used the laser flare-meter (Kowa FM-500) to investigate alteration of the blood-aqueous barrier following uncomplicated penetrating keratoplasty (PK) and in corneal allograft rejection. Examination was performed in 50 eyes of 48 patients after uncomplicated PK (7 days to 12 months after PK), in 20 normal control eyes and in 8 patients with acute allograft rejection. Flare values after uncomplicated keratoplasty slowly decreased in time reaching nearly control values 6 - 12 months postoperatively. They were considerably higher for acute allograft rejection compared to eyes following uncomplicated PK and normal control group. Actually, they tended to diminish gradually after systemic and topical administration of steroids and/or immunosuppressants. Application of laser tyndalometry has been proven to be highly useful in the follow up of patients after perforating keratoplasty-especially high risk grafts, it helps to detect objectively early allograft rejection and is beneficial in monitoring the effectiveness of the treatment.
机译:本研究的目的是在渗透角膜术后使用激光闪光表来量化,随着激光喇叭口血液 - 水性屏障的改变。这可能诊断出于早期同种异体移植抑制的眼睛中这种屏障的客观地破坏,甚至可能在临床症状之前可能有助于监测治疗的疗效。我们使用激光闪光仪(KOWA FM-500)来调查在简并复杂的穿透角膜术(PK)和角膜异种移植物排出后的血液水屏障的改变。在48名患者的50只眼睛中进行检查(PK后7天至12个月),在20例正常对照眼中和8例急性同种异体移植抑制患者中进行。在简单的角膜膜复位后的眩光值缓慢下降到术后6-12个月的几乎控制值。对于不复杂的PK和正常对照组的眼睛相比,它们对急性同种异体移植物抑制相比,它们具有高得多。实际上,它们在系统性和局部施用类固醇和/或免疫抑制剂后往往逐渐减少。激光Tyndomometry的应用已被证明在穿孔角落成形术后患者的后续患者 - 特别是高风险移植物,有助于检测客观早期同种异体移植排斥,并有利于监测治疗的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号